UNC6852, 98%

Name: UNC6852, 98% | 2688842-08-0
Brand: J&K Chemical
SKU: JK9349633_100_MG
Price: 314.7 USD
Availability: OutOfStock

Cat. No JK9349633_100_MG

Vendor: J&K Chemical

Product Information

Product Name

UNC6852, 98%

Brand Name

J&K

Product Number

9349633

CAS

2688842-08-0

Molecular Formula

C43H48N10O6S

Molecular Weight

832.97

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

(2S,4R)-1-((S)-2-(4-(4-(5-((furan-2-ylmethyl)amino)-1,2,4triazolo4,3-cpyrimidin-8-yl)benzamido)butanamido)-3

PubChem CID

146014466

IUPAC Name

(2S,4R)-1-(2S)-2-4-4-5-(furan-2-ylmethylamino)-1,2,4triazolo4,3-cpyrimidin-8-ylbenzoylaminobutanoylamino-3,3-dimethylbutanoyl-4-hydroxy-N-4-(4-methyl-1,3-thiazol-5-yl)phenylmethylpyrrolidine-2-carboxamide

InChI Key

PPNNFXIBKLCMTI-WXEAQWFJSA-N

SMILES

CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C@@H3CC@H(CN3C(=O)C@H(C(C)(C)C)NC(=O)CCCNC(=O)C4=CC=C(C=C4)C5=CN=C(N6C5=NN=C6)NCC7=CC=CO7)O

Properties

Density

1.40±0.1

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2024-04-12

DOI: 10.1021/acs.jmedchem.4c00538

Current advances and development strategies of orally bioavailable PROTACs

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2023-12-05

DOI: 10.1016/j.ejmech.2023.115793

Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2022-03-05

DOI: 10.1016/j.ejmech.2022.114144

Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2021-01-15

DOI: 10.1016/j.ejmech.2020.112981

Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2020-12-07

DOI: 10.1021/acs.jmedchem.0c01344

UNC6852, 98%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader

Current advances and development strategies of orally bioavailable PROTACs

Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs

Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer

UNC6852, 98%

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

UNC6852, 98%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader

Current advances and development strategies of orally bioavailable PROTACs

Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs

Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer

UNC6852, 98%

Related Product

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

#title#

Login

Register